Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new reciprocal tariffs on India exempt the pharmaceutical sector. What Happened: While appearing on the Somebody's Gotta Win With Tara Palmeri podcast earlier this week,

The last 30 years do not give us a lot of insight about the next 30 years. We have to look much further back in history for lessons.”

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite India's strong presence in the US generics market, potential tariffs may increase costs for US consumers and create supply chain challenges.

US President Donald Trump has announced a 25 per cent tariff on vehicles not assembled in the US, effective April 3.

Foreign investors pulled out heavily from Indian equities in the first week of April, reacting to US President Donald Trump's reciprocal tariffs. According to data from the National Securities Depository Ltd (NSDL),

Donald Trump reported on Truth Social that Vietnam wants zero tariffs in trade negotiations with the US. He is involved in discussions with India, Israel, and Vietnam to expedite trade deals as the ta

The price tag for a slew of electronics may significantly rise following President Donald Trump’s implementation of sweeping reciprocal tariffs. The radical shift in foreign trade policy, which is set to launch on April 9,

Stunned to see their own exports punished harshly, Indians are picking through the wreckage for signs of hope. There’s some but not a lot.